Moderna, Inc. (ETR:0QF)

Germany flag Germany · Delayed Price · Currency is EUR
22.15
-0.93 (-4.01%)
At close: Aug 25, 2025, 5:30 PM CET
-4.01%
Market Cap8.25B
Revenue (ttm)2.62B
Net Income (ttm)-2.47B
Shares Outn/a
EPS (ttm)-6.41
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,350
Average Volume1,241
Open22.96
Previous Close23.08
Day's Range22.15 - 23.30
52-Week Range20.18 - 75.20
Beta1.83
RSI34.09
Earnings DateJul 31, 2025

About Moderna

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company’s respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, su... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 5,800
Stock Exchange Deutsche Börse Xetra
Ticker Symbol 0QF
Full Company Profile

Financial Performance

In 2024, Moderna's revenue was $3.24 billion, a decrease of -52.75% compared to the previous year's $6.85 billion. Losses were -$3.56 billion, -24.46% less than in 2023.

Financial numbers in USD Financial Statements

News

Trump Administration Plans To Pull COVID-19 Vaccines Off Market 'Within Months'

The Trump administration is preparing to remove COVID-19 vaccines from the U.S. market "within months," according to a close associate of Health and Human Services Secretary Robert F. Kennedy Jr . Sho...

1 day ago - Benzinga

30 Stocks That Could Rally 30% or More

Analysts say these S&P 500 stocks have at least 30% price upside over the next year or so.

1 day ago - Kiplinger

Moderna Stock Is Trading Higher Friday: What's Going On?

Full story available on Benzinga.com

4 days ago - Benzinga

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has autho...

4 days ago - Wallstreet:Online

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS Newswire / August 22, 2025 / Moderna announced today that Health Canada has autho...

4 days ago - Accesswire

Moderna to Present at Upcoming Conferences in September 2025

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences: Morgan Stanley's 23rd Annual Global He...

6 days ago - Accesswire

Moderna to Present at Upcoming Conferences in September 2025

CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:Morgan Stanley's 23rd Annual Global Hea...

6 days ago - Wallstreet:Online

NIH cancels mRNA vaccine contracts, citing lack of public trust

National Institutes of Health Director Jay Bhattacharya claims the federal government recently cancelled millions of dollars' worth of mRNA research contracts because the general public does not trust...

13 days ago - The Hill

FDA may pull authorization for Pfizer COVID shot for kids under 5

The Food and Drug Administration (FDA) is considering revoking the authorization of Pfizer’s COVID-19 vaccine for healthy children under 5 years old, the company confirmed Wednesday. The move would ad...

13 days ago - The Hill

Moderna Options Trading: A Deep Dive into Market Sentiment

Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ: MRNA). And retail traders should know. We noticed this today when the trades showed up on publicly available opt...

13 days ago - Benzinga

What's Driving the Market Sentiment Around Moderna?

Moderna's (NYSE: MRNA) short percent of float has fallen 4.88% since its last report. The company recently reported that it has 63.02 million shares sold short , which is 22.63% of all regular shares...

14 days ago - Benzinga

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply

View Preview Pfizer Inc.'s (NYSE: PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and pro...

15 days ago - Benzinga

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply

Pfizer Inc.'s PFE COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna Inc. MR...

15 days ago - Benzinga

The 3 Things That Matter for Moderna Now

The company is still trying to prove that it isn't just a pandemic play.

16 days ago - The Motley Fool

RFK Jr has slashed vaccine research. You need to know how perilous that is for the world | Devi Sridhar

The avian flu virus is now just one mutation away from easier transmission among humans. Donald Trump’s health chief is a grave risk to world health Prof Devi Sridhar is chair of global public health ...

16 days ago - The Guardian

Pfizer Covid vaccine for young children may not be renewed by FDA

Email obtained by Guardian says Pfizer was told approval may not be granted, meaning Moderna may have to fill gap Pfizer’s Covid vaccine for young children may not be renewed by the US Food and Drug A...

18 days ago - The Guardian

Moderna’s stock takes a hit as RFK Jr. backs out of some mRNA vaccine deals

Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the biotechnology company’s vaccines and said it would cancel some contracts and stop fundi...

20 days ago - MarketWatch

Check Out What Whales Are Doing With MRNA

Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ: MRNA). And retail traders should know. We noticed this today when the trades showed up on publicly available opt...

20 days ago - Benzinga

Despite RFK’s funding block, mRNA vaccines are too impressive to ignore

Scientists fear decision may increase vaccine hesitancy, but other countries are still willing to invest in research It was a blow many were braced for, yet the block on US funding for mRNA vaccines b...

20 days ago - The Guardian

Is RFK Jr right to pull mRNA vaccine research funding?

The US is withdrawing $500m for vaccines for diseases like flu and Covid. Health correspondent James Gallagher asks if it's the right call.

20 days ago - BBC

RFK Jr cancels $500 million in mRNA research, HHS to prioritize 'safer' vaccine alternatives

Trump administration's Health and Human Services Department cancels 22 mRNA vaccine contracts totaling roughly $500 million, with Health Secretary Kennedy announcing a transition to 'safer' alternativ...

21 days ago - Fox News

Moderna: RSV Upside Slim, Cash Burn Heavy

21 days ago - Seeking Alpha